Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02358876 · ClinicalTrials.gov registry record
BradyXplore Phase II: Bradykinesia Feature Extraction System
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 32
- Enrollment target
NCT02358876: Completed study, sponsored by Great Lakes NeuroTechnologies.
NCT02358876 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02358876 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
Study objectives are to improve motion sensor algorithms for measuring bradykinesia in the clinic and the home, evaluate test-retest reliability of motion sensor algorithms for measuring bradykinesia compared to clinician raters, determine if participant-perceived symptom severities correlate with motion sensor measures, determine if speed, amplitude, and rhythm fluctuate differentially throughout the day in individuals with implanted deep brain stimulation systems, receive feedback on the usability of Kinesia One, and evaluate Kinesia One compliance in the home.
Primary Outcome
Percentage of Kinesia One assessments performed as directed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-07 |
What the finished NCT02358876 record still lists
NCT02358876 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02358876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02358876 about?
NCT02358876 is a clinical study titled "BradyXplore Phase II: Bradykinesia Feature Extraction System". Study objectives are to improve motion sensor algorithms for measuring bradykinesia in the clinic and the home, evaluate test-retest reliability of motion sensor algorithms for measuring bradykinesia compared to clinician raters, determine if participant-perceived symptom severities correlate with m...
What is the current status of trial NCT02358876?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2015-02. Estimated completion is 2015-07.
Who is sponsoring clinical trial NCT02358876?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia